Rheumatoid diseases cause chronic inflammation, pain, and joint damage, significantly impacting quality of life. Current treatments have limited efficacy and adverse effects. Cannabinoids show promise for their anti-inflammatory and analgesic properties in preclinical studies, but clinical evidence is mixed, with no established recommendations for cannabis use in treatment.